Related Experiment Videos

Hypothyroidism in children: diagnosis and treatment

Nuvarte Setian Setian1

  • 1Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo, SP, Brazil. nuvarte@uol.com.br

Jornal De Pediatria
|November 15, 2007
PubMed

Insights

Early diagnosis and treatment of pediatric hypothyroidism, including congenital and subclinical forms, are crucial for normal growth and neurodevelopment. Pediatricians must remain vigilant for conditions like Hashimoto

Area of Science:

  • Pediatric Endocrinology
  • Thyroidology
  • Developmental Pediatrics

Background:

  • Hypothyroidism significantly impacts fetal and childhood development, affecting growth and neurological maturation.
  • Early identification and management are vital to prevent irreversible damage.

Purpose of the Study:

  • To provide an updated overview of pediatric hypothyroidism, covering its causes, diagnosis, and management.
  • To highlight the importance of neonatal screening and the challenges in managing subclinical cases.

Main Methods:

  • Comprehensive review of original articles, review articles, and books.
  • Synthesis of current data on etiopathogeny, screening, diagnosis, and treatment.

Main Results:

  • Congenital hypothyroidism screening enables early diagnosis and treatment, preventing developmental issues.
  • Subclinical hypothyroidism and Hashimoto's thyroiditis require careful management due to potential impacts on growth and neurodevelopment.
  • Severe hypothyroidism can disrupt pubertal development, and transcription factors play a role in thyroid embryogenesis.

Conclusions:

  • Thyroid hormones are essential for normal growth and brain development from fetal life onwards.
  • Neonatal screening is critical for preventing irreversible damage from congenital hypothyroidism.
  • Pediatricians must be alert to subclinical hypothyroidism and Hashimoto's thyroiditis to safeguard children's physical, neurological, and psychological development.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...